Best High Dividend Stocks To Buy Right Now

Related RSH Stock Market Sell-Off Making This Sector an Attractive Buy? Sozzi's Retail Roundup: Radio Shack Abuzz After Super Bowl, But Still Struggling

Posted-In: News Options Markets Movers

(c) 2014 Benzinga does not provide investment advice. All rights reserved.

  Most Popular Five Star Stock Watch: AT&T More Big Moves In Social Media Short Interest (LNKD, TWTR, ZNGA) 7 Stocks With High Dividend Yields Caterpillar vs. John Deere – Which Would You Rather Build With? Friday's Apple Recap Tesla Plans Boosting Lithium ETF (LIT, TSLA, ROC, FMC, SQM)

Best High Dividend Stocks To Buy Right Now: Fresh Start Private Management Inc (CEYY)

Fresh Start Private Management, Inc. (FSPM), incorporated on January 28, 2008, is an alcohol treatment and rehabilitation company. The Company has developed a patented treatment that delivers target therapeutic levels of Naltrexone that significantly reduce patients’ cravings for alcohol.

The program is administered on an outpatient basis with patients need not missing more than a day of work and can receive treatment without co-workers or even family members being aware. The Company operates in the Unites States.

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap stocks Fresh Start Private Management Inc (OTCMKTS: CEYY), 7 Star Entertainment Inc (OTCMKTS: SAEE) and Refill Energy, Inc (OTCMKTS: REFG) have been getting some attention lately in various investment newsletters thanks to paid promotions. Of course, there is nothing wrong with a properly disclosed promotional or investor relations campaign, but unwary investors or traders could find themselves in trouble if they are not careful. So do these three small caps have what it takes to remain hot? Here is a quick reality check before you invest or trade:

    Fresh Start Private Management Inc (OTCMKTS: CEYY)is Expecting “Exponential Revenue Growth”

    Small cap Fresh Start Private Management is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. On Friday, Start Private Management rose 13.99% to $0.044 for a market cap of $5.19 million plus CEYY is down 92.7% since last March according to Google Finance.

Best High Dividend Stocks To Buy Right Now: Opexa Therapeutics Inc.(OPXA)

Opexa Therapeutics, Inc., a biopharmaceutical company, develops patient-specific cellular therapies for the treatment of autoimmune diseases. Its principal product includes Tovaxin, a personalized cellular immunotherapy treatment that completed Phase IIb clinical study for multiple sclerosis. Tovaxin is derived from T-cells isolated from peripheral blood, expanded ex vivo, and reintroduced into the patients via subcutaneous injections. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics, Inc. was founded in 2003 and is based in The Woodlands, Texas.

Advisors’ Opinion:

  • [By CRWE]

    Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), reported that the Company is rebranding its leading MS therapy with the new name Tcelna(TM).

Best High Dividend Stocks To Buy Right Now: Alterra Capital Holdings Ltd(ALTE)

Alterra Capital Holdings Limited, together with its subsidiaries, provides specialty insurance and reinsurance products to corporations, public entities, and property and casualty insurers in North America, Europe, and internationally. It offers professional liability products, which include errors and omissions insurance, employment practices liability insurance, and directors and officers insurance; excess liability products, such as excess umbrella liability insurance, excess product liability insurance, excess medical malpractice insurance, and excess product recall insurance; and property insurance, as well as provides airline, general aviation, and aerospace insurance. The company also offers reinsurance products consisting of agriculture, auto, aviation, credit/surety, general casualty, marine and energy, medical malpractice, professional liability, property, whole account, and workers? compensation reinsurance. In addition, it offers general liability, inland mari ne, and ocean marine insurance; accident and health insurance and reinsurance, financial institutions insurance, and surety reinsurance; and employers? and public liability insurance, and medical malpractice insurance, as well as life and annuity reinsurance. The company was formerly known as Max Capital Group Ltd. and changed its name to Alterra Capital Holdings Limited in May 2010. Alterra Capital Holdings Limited was founded in 1999 and is headquartered in Hamilton, Bermuda.

Advisors’ Opinion:

  • [By Steve Symington]

    About that whale…
    If that weren’t enough, Markel also announced this morning it has officially completed its $3 billion acquisition of Alterra (NASDAQ: ALTE  ) , which, as I noted back in February, was a radical departure from Markel’s typically smaller buyout targets. While it will undoubtedly take some time to fully integrate Alterra’s operations, management expressed excitement for Alterra’s ability to help Markel expand its global footprint in the insurance and reinsurance market.

Best High Dividend Stocks To Buy Right Now: CytRx Corporation(CYTR)

CytRx Corporation, a biopharmaceutical research and development company, engages in the development of human therapeutics, specializing in oncology. Its drug development pipeline includes INNO-206, which is in Phase II clinical trials for the treatment of soft tissue sarcomas and is in Phase Ib/2 clinical trials for the treatment of solid tumors; and tamibarotene that is in Phase II clinical trials for the treatment of non-small-cell lung cancer and acute promyelocytic leukemia. The company also develops Bafetinib, which is in Phase II clinical trials for the treatment of B-cell chronic lymphocytic leukemia and advanced prostate cancer, as well as in pharmacokinetic clinical trial for brain cancer. CytRx Corporation was founded in 1985 and is headquartered in Los Angeles, California.

Advisors’ Opinion:

  • [By James Johnson]

    CytRx Corporation’s (NASDAQ: CYTR  ) oncology drug, aldoxorubicin, an improved version of the chemotherapeutic agent doxorubicin, recently received FDA approval to extend the dosing in a Phase 3 clinical trial. This trial is evaluating aldoxorubicin as a second-line treatment for soft-tissue sarcomas (STS). In April 2013, the FDA granted Special Protocol Assessment (SPA) to aldoxorubicin as a second-line treatment for STS with a maximum dosing of six cycles. The drug is given by a 30 minute IV infusion once every three weeks which is one cycle. The extension of the treatment cycle was based on aldoxorubicin’s superior cardiac safety and efficacy profile compared to doxorubicin in prior studies. Aldoxorubicin was found to be safer than doxorubicin, a toxic drug associated with side effects such as cardiovascular events and heart damage in cancer patients. The extended dosing could allow CytRx to demonstrate even higher progression-free survival (PFS) efficacy re sults compared to the Phase 2b trial for advanced STS with this drug. The company plans to initiate the Phase 3 trial during the first quarter of 2014.

  • [By John Udovich]

    Small cap biotech stock CytRx Corporation (NASDAQ: CYTR) started the new year jumping 10.05% for an almost 50% rise over the past week or so after it surged 68.2% in one day in early December, meaning it might be time to take a closer look at the stocks along with the performance of biotech ETF benchmarks like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI). I should mention that we have recently added CytRx Corporation to our SmallCap Network Elite Opportunity (SCN EO) portfolio since December 20th and we are up around 49% since then.

  • [By Bryan Murphy]

    If you’re reading this, then odds are you already know that small caps WidePoint Corporation (NYSEMKT:WYY), CytRx Corporation (NASDAQ:CYTR), and Elephant Talk Communications Corp. (NYSEMKT:ETAK) are among the recent big winners from the small cap stock realm. ETAK is up 100% since the end of October, largely spurred by encouraging numbers in its third-quarter results. CYTR shares have rallied more than 150% in just the past three days on the heels of an announcement that a cancer drug the biotech company is developing has shown wonderful Phase 2 results. And, WYY has advanced 93% over the past month or so, thanks to Q3’s earnings announcement, though the trading public – and then the media – certainly took the ball and ran with it.

Best High Dividend Stocks To Buy Right Now: RSC Holdings Inc.(RRR)

RSC Holdings Inc., together with its subsidiaries, engages in the rental of construction and industrial equipment primarily in the United States and Canada. It offers approximately 900 categories of equipment, including backhoes, forklifts, air compressors, scissor lifts, aerial work platform booms, and skid-steer loaders; and smaller items, such as pumps, generators, welders, and electric hand tools. The company also provides safety equipment, which comprise hard hats and goggles; consumables that include blades and gloves; tools comprising ladders and shovels; and other ancillary products. In addition, it sells new equipment; and used rental equipment, merchandise, and other related items. The company sells its products to industrial or non-construction related companies, and construction companies. As of December 31, 2011, it operated through a network of 440 rental locations in 43 states in the United States; and 3 Canadian provinces. The company is headquartered in Sc ottsdale, Arizona.

Advisors’ Opinion:

  • [By Holly LaFon] s a machinery rental service for construction, industrial, petrochemical, governmental and manufacturing businesses in the U.S. and Canada. RSC tends to benefit in economic downturns, as more businesses turn to renting rather than buying equipment to cut costs. Rented equipment rose 20.7% percent (the sixth consecutive quarter of double-digit growth) and rental revenue increased 27% in the fourth quarter of 2011, compared to last year.

    United Rentals (URI), one of RSC’s largest competitors, had a rental revenue increase of 18.5% in the fourth quarter compared to last year, which included a 6.7% increase in rental rates.

    The company’s fleet utilization also increased to 69% for 2010, up 510 bps from 2010, and it spent $616 million in gross rental capital expenditures to keep up with demand.

    Part of the growth is a result of management’s decision in 2006 to expand beyond the cyclical construction market to the largely untapped non-construction and indu strial markets that need machinery for mining and oil and gas drilling.

    RSC Holdings has a market cap of $2.26 billion; its shares were traded at around $22.15 with a P/E ratio of 197.91 and P/S ratio of 1.49.

    Magma Design Automation Inc. (LAVA)

    Magma Design Automation is a Silicon-Valley company that develops electronic design automation software products and solutions, from concept to completion. It has had relatively flat free cash flow growth for the last ten years and an average annual earnings growth of 1.8%.

    On November 30, it announced it was going to be acquired by Synopsys Inc., for $7.35 per share, or $507 million net of cash and debt. Shareholders sued the company on December 1 saying that the sell price was too low, as it closed as high as $8.50 per share in July 2011 and analysts had set price targets at up to $11.00 per share.

    Grantham bought 1,663,500 shares of the company at an average price of $5.70 in the fourth quarter.

    Gold Fields Ltd.

Best High Dividend Stocks To Buy Right Now: Interactive Brokers Group Inc (IBKR)

Interactive Brokers Group, Inc. (IBG, Inc.) is a holding company. The Company is an automated global electronic broker and market maker specializing in routing orders and executing and processing trades in securities, futures, foreign exchange instruments, bonds and mutual funds on more than 100 electronic exchanges and trading venues worldwide. In the United States, it conducts its business in Greenwich, Connecticut, Chicago, Illinois and Jersey City, New Jersey. Abroad, the Company conducts business through offices located in Canada, England, Switzerland, Hong Kong, India, Australia and Japan. It operates in two segments: electronic brokerage and market making. As of December 31, 2011, the Company owned 11.5% in IBG LLC, the holding company for its businesses. The Company is the sole managing member of IBG LLC.

As a direct market access broker, the Company serves the customers of both traditional brokers and prime brokers. It provides its customers with orde r management, trade execution and portfolio management platform. Its customers can simultaneously access different financial markets worldwide and trade across multiple asset classes (stocks, options, futures, foreign exchange (forex), bonds and mutual funds) denominated in 17 different currencies, on one screen, from a single account based in any currency. Its bank and broker-dealer customers may white label its trading interface (make its trading interface available to their customers without referencing its name), or can select from among its modular functionalities, such as order routing, trade reporting or clearing on specific products or exchanges. During the year ended December 31, 2011, the Company introduced the Interactive Brokers Information System (IBIS). IBIS is a market information workspace, which provides subscribers with real-time market data, research, analytics, stock scanners, charts and alerts. As a market maker, the Company provides continuous bid and o ffer quotations on over 867,000 securities and futures produ! cts listed on electronic exchanges worldwide.

Electronic Brokerage-Interactive Brokers

During 2011, Electronic brokerage represented 50% of net revenues from electronic brokerage and market making combined. It conducts its electronic brokerage business through its Interactive Brokers (IB) subsidiaries. As an electronic broker, it executes, clears and settles trades worldwide for both institutional and individual customers.

The Company competes with TD Ameritrade, The Charles Schwab Corporation, Goldman Sachs, Morgan Stanley, Bank of America Merrill Lynch and Morgan Stanley Smith Barney.

Market Making-Timber Hill

During 2011, Market making represented 50% of net revenues from electronic brokerage and market making combined. The Company conducts its market making business through its Timber Hill (TH) subsidiaries. It provides liquidity by offering bid/offer spreads over a base of over 867,000 tradable, exchang e-listed products, including equity derivative products, equity index derivative products, equity securities and futures. Together with its electronic brokerage customers, in 2011 it accounted for approximately 9.9% of exchange-listed equity options traded worldwide and approximately 10.1% of exchange-listed equity options volume traded on those markets in which it actively trades. The Company’s United States market making activities are conducted through Timber Hill LLC (TH LLC), a securities broker-dealer that conducts market making in equity derivative products, equity index derivative products and equity securities.

TH LLC is a member of the Boston Options Exchange, BATS exchange, Chicago Board Options Exchange, Chicago Mercantile Exchange, Chicago Board of Trade, International Securities Exchange, NYSE AMEX Options Exchange, NYSE Arca, OneChicago, NASDAQ OMX PHLX and the New York Mercantile Exchange. TH LLC also conducts market making activities in Mexic o at the MEXDER and the Mexican Stock Exchange and in Brazil! at the S! ao Paulo Stock Exchange and the Brazilian Mercantile and Futures Exchange. The Company conducts market making activities in Canada through its Canadian subsidiary, Timber Hill Canada Company (THC) at the Toronto Stock Exchange and Montreal Exchange. In addition, it participates in stock trading at the Electronic Communications Networks (ECNs) in both the United States and Canada.

The Company’s European, Asian, and Australian market making subsidiaries, primarily Timber Hill Europe AG (THE), conducts operations in 20 countries, comprising the securities markets in these regions. Its other European operations are conducted on the London Stock Exchange; the Weiner Borse AG; the Copenhagen Stock Exchange; the Helsinki Stock Exchange; the NYSE Euronext exchanges in Amsterdam, Paris, Brussels and London; NASDAQ OMX Nordic in Sweden, Finland and Denmark; the Swedish Stock Exchange; the MEFF and Bolsa de Valores Madrid in Spain; the IDEM and Borsa Valori de Milano in Milan, and the OTOB in Vienna.

The Company competes with Goldman Sachs, Morgan Stanley, UBS, Citigroup, Bank of America Merrill Lynch, Citadel, Susquehanna, Wolverine Trading, Group One Trading, Peak6 and Getco.

Advisors’ Opinion:

  • [By Steven Russolillo]

    “While some companies like to play dumb to reading the writing on the wall, it appears Caterpillar has acted decisively in addressing a slowdown in orders and as a result the outlook is in slightly less need of bulldozing than two quarters ago,” said Andrew Wilkinson, chief market analyst at Interactive Brokers LLC(IBKR).

  • [By Eric Volkman]

    Interactive Brokers (NASDAQ: IBKR  ) results for the company’s Q1 have been unveiled, revealing fairly steep drops in its top and bottom lines. For the quarter, revenue was $216 million, or nearly 30% below the $304 million the firm posted in the same period the previous year. Net income also went down by 41% on a year-over-year basis to hit $6.6 million ($0.14 per diluted share). The same line item for Q1 2012 was $11.1 million ($0.27).

  • [By Monica Gerson]

    Interactive Brokers Group (NASDAQ: IBKR) is projected to post its Q3 earnings at $0.34 per share on revenue of $336.48 million.

    Joe’s Jeans (NASDAQ: JOEZ) is estimated to post its Q3 earnings at $0.02 per share on revenue of $33.37 million.

  • [By Matt Koppenheffer]

    For Vanguard, the top-ranked online broker in the world according to this report, that’s good news — a happy customer is a loyal customer. It’s likewise good news for competitors like TD AMERITRADE  (NYSE: AMTD  ) — which ranked No. 2 for its thinkorswim service and No. 8 for its main platform — Charles Schwab  (NYSE: SCHW  ) (No. 3), and Interactive Brokers  (NASDAQ: IBKR  ) (No. 4 for its U.S. operations, No. 5 for its offering in Germany).

Best High Dividend Stocks To Buy Right Now: Pharmerica Corporation(PMC)

Pharmerica Corporation operates as an institutional pharmacy services company in the United States. It offers services to healthcare facilities and provides management pharmacy services to hospitals. The company purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. It also provides consultant pharmacist services for customers to comply with the federal and state regulations applicable to nursing homes; and medical records services. In addition, the company offers various ancillary services, such as infusion therapy products and services; and hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs to various hospitals. PharMerica Corporation operates approximately 95 institutional pharmacies in 44 s tates and provides pharmacy management services to 91 hospitals. Its customers primarily include institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and other long-term alternative care settings. The company is headquartered in Louisville, Kentucky.

Advisors’ Opinion:

  • [By Sean Williams]

    What: Shares of PharMerica (NYSE: PMC  ) , a pharmacy services company, jumped as much as 11% after reporting better-than-expected first-quarter results.

  • [By Josh Arnold]

    PharMerica Corporation (PMC) is a pharmacy services company that operates in several segments in the US. The company offers services to healthcare facilities, pharmacy management services and specialty infusion to patients outside of hospitals. PMC’s primary customers are assisted living centers, hospitals, and other long term care facilities. The company services just under 200 locations in 45 states in the US and produces about $1.7 billion in annual revenue. With shares near the bottom of their 52 week range following a nasty selloff, is there any value in PMC or is it a classic trap? I’ll argue here that PMC’s structural tailwinds for earnings including demographics and consumer preference shifts will increase PMC’s ability to convert revenue into profit and drive the stock higher.

Best High Dividend Stocks To Buy Right Now: Peabody Energy Corporation(BTU)

Peabody Energy Corporation engages in the mining of coal. It mines, prepares, and sells thermal coal to electric utilities and metallurgical coal to industrial customers. The company owns interests in 30 coal mining operations located in the United States and Australia, as well as owns joint venture interest in a Venezuela mine. It is also involved in marketing, brokering, and trading coal. In addition, the company develops a mine-mouth coal-fueled generating plant; and Btu Conversion projects that are designed to convert coal to natural gas or transportation fuels; and clean coal technologies. As of December 31, 2011, it had 9 billion tons of proven and probable coal reserves. The company was founded in 1883 and is headquartered in St. Louis, Missouri.

Advisors’ Opinion:

  • [By Reuben Brewer]

    Relatively weak demand for thermal coal in China has pushed coal prices lower in Australia. That’s a problem for big miners like Rio Tinto (NYSE: RIO  ) , BHP Billiton (NYSE: BHP  ) , and Peabody Energy (NYSE: BTU  ) . However it could add to the allure of uranium miner Cameco (NYSE: CCJ  ) .

  • [By Aaron Levitt]

    While Gazprom will be the major winner of this, the potential losers include U.S. coal stocks Arch Coal (ACI) and Peabody Energy (BTU). Both have already felt the one-two punch of dwindling demand here at home coupled with rising environmental regulations. As two of the biggest suppliers to China, the deal could mean more losses for investors as the Asian Dragon replaces coal with Russian piped gas.

  • [By Ben Levisohn]

    The last six months have been good to coal miners like Alpha Natural Resources (ANR), Walter Energy (WLT), Consol Energy (CNX) and Peabody Energy (BTU), which all gained more than 10%. The last month, not so much, as many have experienced double-digit losses.

  • [By Ben Levisohn]

    The Market Vectors Coal ETF (KOL) dropped 21% last year, but has gained 6.3% during the past six months. Peabody Energy (BTU), meanwhile, fell 25% last year but has climbed 27% during the past six months, Alpha Natural Resources (ANR) declined 27% but has gained 41% and Arch Coal (ACI) plunged 38% but gained 25% during the last six months. Consol Energy (CNX) rose 20% last year and gained 19% during the last six months.

Best High Dividend Stocks To Buy Right Now: Synta Pharmaceuticals Corp.(SNTA)

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drug candidates for treating severe medical conditions, including cancer and chronic inflammatory diseases. The company has two drug candidates in clinical trials for treating multiple types of cancer and various drug candidates in the preclinical stage of development. Its oncology product portfolio includes Ganetespib, an Hsp90 inhibitor in various phase 1, 2, and 3 clinical trail programs for various types of cancers, including non-small cell lung cancer, gastrointestinal stromal tumors, hematologic cancers, colorectal cancer, gastric cancer, small cell lung cancer, ocular melanoma, pancreatic cancer, prostate cancer, breast cancer, hepatocellular cancer, and solid tumors; Elesclomol, a mitochondria-targeting agent in phase 2 clinical trails for non-small cell lung cancer and ovarian cancer, as well as in phase 1 clinical trail for acut e myeloid leukemia; STA-9584, a vascular disrupting agent in preclinical development stage for prostate cancer; and various Hsp90 inhibitors in preclinical development stage for cancers. The company?s inflammatory diseases product portfolio includes calcium release activated calcium modulator (CRACM) channel inhibitors in preclinical development stage for autoimmune diseases, respiratory conditions, and transplantation; and IL-12/23 inhibitors in lead optimization stage for autoimmune diseases. It has a license agreement with Hoffman-La Roche for the development and commercialization of compounds from CRACM. Synta Pharmaceuticals Corp. was incorporated in 2000 and is based in Lexington, Massachusetts.

Advisors’ Opinion:

  • [By James E. Brumley]

    Looks out Synta Pharmaceuticals Corp. (NASDAQ:SNTA), and AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), you’re on notice too. Corcept Therapeutics Incorporated (NASDAQ:CORT) is nipping at your heels, and better still, shares of the company looks like they’re about to dole out a sizeable reward to investors who see the writing on the wall.

  • [By Lauren Pollock]

    Synta Pharmaceuticals Corp.(SNTA) said it intends to offer an unspecified number of shares to the public. The biopharmaceutical company has about 69 million shares outstanding. Shares dropped.

  • [By Sean Williams]

    What: Shares of Synta Pharmaceuticals (NASDAQ: SNTA  ) , a clinical-stage biopharmaceutical company focused on researching and developing cancer and chronic inflammatory therapies, fell as much as 17% following an analyst downgrade after Synta disclosed the departure of its president of research & development.